Daniel Gill

Daniel Gill is a highly experienced professional who has held various roles in the pharmaceutical and biotechnology industry. Currently serving as a Co-Founder and Head of Project Management at Lario Therapeutics, Daniel is dedicated to developing precision medicines for severe neurological disorders. With a background in research and business development, Daniel has also contributed to organizations such as Epidarex Exeed, Orion Biotechnology Switzerland, Wellcome Trust, and NIHR. Their educational background includes degrees in stem cell technology, biochemistry, and continuous professional development in pharmaceutical business development and licensing.